Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Marketing Settlement With DoJ Ends Only Some Investigations

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm will pay $185 million criminal fine for practices related to Trileptal, but has yet to settle on civil penalties relating to its marketing practices.
Advertisement

Related Content

Novartis Settlement Encompasses Whistleblower Claims Of Kickbacks For Diovan Prescribing
Novartis Settlement Encompasses Whistleblower Claims Of Kickbacks For Diovan Prescribing
Litigation In Brief: Elan, Novartis Resolve Federal Marketing Investigations
Litigation In Brief: Elan, Novartis Resolve Federal Marketing Investigations
Novartis Inks Second Off-Label Settlement With DoJ, Paying $72.5 Million Over TOBI Marketing
Novartis Inks Second Off-Label Settlement With DoJ, Paying $72.5 Million Over TOBI Marketing

Topics

Advertisement
UsernamePublicRestriction

Register

PS070154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel